amineptine
Small moleculeexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
- Dopamine D1 and D2 receptorANTAGONIST
Dopamine D1 and D2 receptor antagonist
Amineptine is a selective inhibitor of dopamine reuptake and its effects are selectively exerted on the mesolimbocortical system, resulting in reactivation of this system.
Chemistry & pharmacology
Loading structure…
SMILES
O=C(O)CCCCCCNC1c2ccccc2CCc2ccccc21- Mol. weight
- 337.46 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL418995 ↗
- ChEMBLCHEMBL1697712 ↗
Also known as
- 10,11-dihydrodibenzo(a,d)cyclohept-5-enyl-7-aminoheptanoic acid
- 7-((10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5-yl)amino)heptanoic acid
- amineptin
- amineptin
- amineptine
- amineptine
- amineptine
- amineptine
- amineptine
- amineptine
- amineptine
- amineptine
- amineptine hcl
- amineptine hydrochloride
- amineptin hydrochloride
- amineptin sodium
- amineptin sodium salt
- s 1694
- survector
- survector